The increase of FGFR4 expression in the heart of the CRS mice maybe attributable to the compensatory myocardial hypertrophy induced by MI and the upregulation of its ligand FGF23, and the similar phenomenon has been reported from both experimental and clinical investigations [66, 67]. The gene discussed is FGF23; the disease is cardiac hypertrophy.